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Abstract
Objective: To determine the distribution of conventional cardiovascular disease risk factors in 
hemodialyzed patients in a novel Cameroonian regional hemodialysis center. 
Methods: This was cross-sectional study carried out at the hemodialysis center of the Garoua Regional 
Hospital during the period April to August 2014.  Sociodemographic, clinical, anthropometric and 
biochemical data were assessed.
Results: Our sample population constituted 35 patients with stage V chronic kidney disease (CKD) 
undergoing hemodialysis. Among them, 74.3% were physically inactive while 22.9% and 2.9% presented 
with alcohol and tobacco consumption, respectively. The prevalence of hypertension, diabetes, 
dyslipidemias, overweight and obesity were estimated at 91.4%, 22.9%, 85.7%, 25.7% and 14.8%, 
respectively. There was a significant difference between men and women concerning the mean values of 
diastolic blood pressure (p = 0.036) and HDL cholesterol (p = 0.024). Moreover, the mean systolic (P = 
0.028) and diastolic (P = 0.005) blood pressures were significantly highest in patients with less than a year 
of hemodialysis. 
Conclusion: Our findings suggest that dyslipidemias and other cardiovascular disease risk factors 
frequently occur in hemodialyzed patients in our setting. 
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Distribution de quelques facteurs de risque cardiovasculaires chez des 
patients en hémodialyse : les résultats d'une étude transversale réalisée 
au Cameroun
1,2 3,4 1,2*Ngoufack, T.J.O. , Tamanji, M.T. , Mbouemboue, O.P.
Résumé
Objectif: Déterminer la fréquence des facteurs de risque traditionnels des maladies cardiovasculaires 
chez des patients souffrant d'insuffisance rénale terminale dans un nouveau centre d'hémodialyse 
camerounais. 
Méthode: Une étude transversale a été conduite au Centre Régional d'Hémodialyse de Garoua d'Avril à 
Aout 2015. Les données sociodémographiques, anthropométriques, cliniques et biologiques des patients 
étaient analysées.
Résultats: l'échantillon d'étude comptait 35 patients sous hémodialyse. Parmi eux, 74,3% étaient 
sédentaires, 22,9% consommaient des boissons alcoolisées et 2,9% étaient des fumeurs. Les prévalences 
de l'hypertension artérielle, du diabète, des dyslipidémies, du surpoids et de l'obésité étaient 
respectivement de 91,4%, 22,9%, 85,7%, 25,7% and 14,8%. La pression artérielle diastolique moyenne 
des femmes était plus élevée que celle des hommes (p = 0.036).  Le HDL cholestérol moyen des femmes 
était plus élevée que celui des hommes (p = 0.024). Les patients sous hémodialyse depuis moins un an 
avaient une pression artérielle supérieure à celle des autres. 
Conclusion: nos résultats ont montré que les dyslipidémies et les autres facteurs de risque 
cardiovasculaires sont fréquents chez les patients en hémodialyse dans notre contexte. 
Mots clés: Maladies cardiovasculaires, insuffisance rénale terminale, Néphropathie chronique, 
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2area of 66,090 km , constituting 10.9% of the 
national population and 14.2% of the nation's 
surface area respectively (8). Since there were 
few patients undergoing haemodialysis in the 
centre, all of those suffering from ESRD (stage V 
2CKD, GFR< 15ml/min/1.73m ), who have been 
on haemodialysis at for at least a month and, who 
gave their consent to participate, were 
consecutively included in the study. Patients 
suffering from acute kidney failure, those who 
had not commenced haemodialysis and those 
who did not consented to participate were 
excluded.
Study variables and data collection procedure
Sociodemographic,  clinical and 
anthropometric data were recorded during 
medical visits with the help of a structured 
questionnaire. These were Gender, age, alcohol 
consumption, smoking, physical inactivity, 
systolic blood pressure, diastolic blood pressure, 
height weight and body mass index. Biological 
data were fasting blood glucose, total cholesterol, 
high density lipoprotein (HDL) cholesterol, low 
density lipoprotein (LDL) cholesterol, 
triglycerides, total cholesterol-to-HDLc ratio.
Measurement of anthropometric parameters
Weight measurements were done using a 
mechanical weighing balance (mark: SECA), 
calibrated at the beginning of each day and 
ensuring that the scale was on a flat and stable 
surface. The participants were barefooted, lightly 
dressed and the weight was measured to the 
nearest 100 grams (9). Participants' heights were 
measured using a graduated flexible non-
extensible ribbon tape (Gulick measuring tape©) 
provided with a spring enabling the adjustment of 
the tension applied during measurement and 
having a measurement precision of 0.1cm. The 
participants had to stand barefoot, without any 
headwear, with heels assembled and the tips of 
the feet slightly apart. The reading was performed 
with the help of an incorporated sliding track 
system. Body mass index was calculated using 
the Quetelet formula, stated as weight (kg) 
divided by the square of height (m) and classified 
2as less than 18.5 kg/m   (underweight), 18.5-24.9 
2 2kg/m  (normal weight), 25.0-29.9 kg/m  
2(overweight), and 30.0 kg/m  or more (obesity) 
(9). 
Measurement of clinical and biological 
parameters
Resting blood pressure measurements 
were performed using an electronic blood 
INTRODUCTION
It is well established that persons 
suffering from end stage renal disease are at high 
risk of morbidity and mortality due to 
cardiovascular diseases (1). This is probably 
related to the high prevalence of cardiovascular 
risk factors because several studies indicate that 
traditional cardiovascular disease risk factors are 
more frequent in patients with chronic kidney 
disease (CKD) at dialysis and pre-dialysis stages 
(2). According to the results of the CHOICE 
Study in which 1041 dialysis patients were 
recruited from 19 states in the United States of 
America, participants had a high prevalence of 
diabetes (54%), hypertension (96%), low 
physical activity (80%), hypertriglyceridemia 
(36%), and low HDL cholesterol (33%) (3). More 
recently, the ANSWER study shown that 86% of 
a Spanish incident haemodialysis population had 
hypertension, 43% had dyslipidaemia and 44% 
had a history of cardiovascular disease (4). 
The exact place of these risk factors in 
ESRD in our environment remains insufficiently 
known. Previous observations have focus on the 
lack of renal registries and reliable statistics about 
the prevalence of CKD in the majority of African 
countries (5, 6). However, it has been shown that 
hypertension is the cause of ESRD in 21% of 
patients on renal replacement therapy in South 
Africa (5). Moreover the prevalence of diabetic 
nephropathy is estimated to be 14%-16% in 
South Africa, 23.8% in Zambia, 12.4% in Egypt, 
9% in Sudan, and 6.1% in Ethiopia (7). In 
Cameroon, new operational haemodialysis 
centres have been created throughout the national 
territory, in order to limit deaths from CKD. In 
this context assessing cardiovascular risk factors 
in patients undergoing haemodialysis may play a 
vital role in the development of preventive 
strategies of renal and cardiovascular 
complications in patients with CKD. 
The aim of this study was to determine 
the place of conventional cardiovascular disease 
risk factors in patients with renal failure under 
medical follow-up in a Cameroon regional 
haemodialysis centre.
MATERIALS AND METHODS
Study design, population and selection criteria
This was a cross-sectional study 
conducted in the haemodialysis centre of the 
Garoua Regional Hospital spanning a four-month 
period (15 April – 14 August 2015). The town of 
Garoua represents the administrative capital of 
the North region of Cameroon, having a 
population 2,311,179 inhabitants and a surface 
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RESULTS
A total of 35 patients undergoing 
haemodialysis participated in the study.  Among 
them, there were 25 men and 10 women. 
Following their age groups, 18 of them were 20 - 
49 years old and 17 were 50 years old or above. 
The prevalence of hypertension, diabetes, 
dyslipidaemia, overweight and obesity were 
estimated at 94.4%, 22.9%, 85.7%, 25.7%, 
14.8%, respectively. There was no significant 
difference between men and women concerning 
cardiovascular diseases risk factors, except for 
the mean values of diastolic blood pressure (P = 
0.036) and HDL cholesterol (P = 0.024) (Table 1). 
Following categorization of study 
participants by age group, we observed that 
patients aged 50 years and above were 
significantly more sedentary compared to those 
younger (P = 0.011). Also, the mean fasting blood 
glucose (P = 0.020) and triglyceride (P = 0.030) 
levels were higher in participants aged 50 years 
and above. All other studied variables were 
equivalently distributed between the two age 
groups (Table 2). 
 
DISCUSSION
According to recent data, CKD is on the 
rise worldwide and affects at least one adult out of 
ten (12), with the sub-Saharan population being 
particularly vulnerable. Our study permits the 
provision of additional information on the place 
of conventional cardiovascular disease risk 
factors in a population of patients undergoing 
haemodialysis in a regional haemodialysis centre 
in Cameroon. The results highlighted high 
frequencies of hypertension, diabetes, 
dyslipidaemias and sedentary.
Sedentary Lifestyle
Muscle weakness and excessive fatigue 
constitute some of the complications of concern 
in patients with CKD, especially among those on 
hemodialysis. They carry out reduced physical 
activity which could pose serious cardiac 
implications such as coronary pathologies, 
demonstrating the association of physically 
active lifestyle with a reduction in the occurrence 
of cardiovascular complications during hospital 
stay, which has been previously reported by Jorge 
et al in a Brazilian study (13). Our results 
indicated that 74.8% of patients were sedentary 
We went further to categorize 
patients based on their duration on dialysis, 
where we observed that the mean systolic (P = 
0.028) and diastolic (P = 0.005) blood pressures 
were significantly highest in patients with less 
than a year of haemodialysis (Table 3).
pressure meter (Omron®, BP785, USA) 
calibrated against a manual sphygmomanometer 
daily and following the JNC 7 recommendations 
(10). Fasting blood glucose was measured using a 
glucometer (One touch ultra 2, Lifescan Inc. 
Johnson & Johnson Company, Milpitas, CA 
95035 USA). The rest of the biological 
measurements were done at the Centre Pasteur 
Laboratory, Garoua annex, Cameroon. Serum 
total cholesterol and triglyceride levels were 
determined by spectrophotometry following the 
C H O D - PA P a n d  G P O - PA P m e t h o d s  
respectively. HDL cholesterol levels were 
determined in supernatant solutions following 
precipitation of HDL lipoproteins. Results were 
i n t e r p r e t e d  a n d  a n a l y z e d  f o l l o w i n g  
manufacturer's normal ranges thus; Total 
cholesterol: <5.73 mmol/l: Triglycerides: 
<1.46mmol/l, HDL cholesterol: 0.9–2.1mmol/l. 
LDL cholesterol calculated following the 
Friedwald's equation [LDL (mmol/l) = TC–HDL-
TG/2.2] for all triglyceride measurements less 
than 4mmol/l (11), and results classified as low 
risk for values < 3.69 mmol/l. Total cholesterol-
to-HDLc ratio was report as low risk for 
atherogenesis for values ≤ 4.85. Dyslipidemias 
were defined using manufacturer's normal ranges 
as total cholesterol level ≥  5.73 mmol/l, 
triglyceride level ≥  1.46 mmol/l, HDL 
cholesterol level ≤ 0.9 mmol/l or LDL cholesterol 
level > 4.85 mmol/l.
Statistical analyses
Data were recorded using the Census and 
Survey Processing System (CSPro) 4.1 software 
and later imported into the Statistical Package for 
the Social Sciences (SPSS) 20.0 software for 
statistical analyses. Results for qualitative or 
categorical variables were presented as 
percentages and those of continuous quantitative 
variables as means ± SD, all in the same tables. 
Comparisons of frequencies and means were 
done using the Pearson's Chi square and the 
ANOVA tests respectively. P-values equals or 
less than 0.05 were consider as statistically 
significant.
Ethical considerations: This study obtained 
approval from the Local Ethical Committee (Ref: 
1215/L/RC/RN/DSP/HR/GRA/ CLE) and the 
administrative authority of the Garoua Regional 
Hospital. Participants were well informed on the 
merits and demerits of this study after which 
those interested provided a written consent to 
participate. 
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failed to demonstrate associations between 
hypertension and gender, participants' age, and 
duration of dialysis, although the mean diastolic 
BP was significantly higher in females compared 
to males, being identical to the reports of 
Burmeister et al. (14), and the means of both 
systolic and diastolic BP were observed to be 
significantly higher in patients with less than a 
year of haemodialysis compared to patients with 
a longer duration of dialysis. This may be the 
result of the fact that hypertension is both a cause 
and a consequence of chronic renal failure 
leading to a high prevalence of this risk factor in 
haemodialysis patients, and also, owing to the 
fact that frequent haemodialysis reduces blood 
pressure (21). The fact that blood pressure is 
difficult to control in the initial phases of 
haemodialysis and that dialysis causes a sudden 
rise in blood pressure may be a possible 
contributing factor (21). 
Diabetes
Resistance to insulin is a characteristic of 
type 2 diabetes and chronic uremia (22). Insulin 
resistance and decreased insulin clearance lead to 
fluctuations in plasma glucose making glycemic 
control difficult in diabetic patients with ESRD 
(23). The prevalence of diabetes was 22.8% in 
this study and all diabetic participants were of the 
type 2 category. This rate is close to the 21.6% 
reported by Kabbali et al. in a Moroccan 
population of patients undergoing haemodialysis 
(24). Conversely, El Farouki et al. reported a 
41.5% prevalence in another Moroccan study 
(25), which is higher than the one reported in the 
present study. Since diabetes is a frequent cause 
of CKD, the variation of its prevalence among 
patients in haemodialysis may reflect the same 
variation in the local population. However, 
patients undergoing haemodialysis in our study 
recorded a mean fasting blood glucose level of 
1.00 ± 0.29 g/l, similar to that reported by 
Sobngwi et al. in another Cameroonian study 
(26).
Obesity
In this study, 51.5% of patients on 
dialysis had a normal BMI, while 25.7%, and 
14.8% were overweight and obese respectively. 
This is in line with the CORDIAL study which 
recorded 52.2%, 29.4% and 12.4% normal, 
overweight, and obese respectively (14).
Dyslipidemias
We observed a 85.7% prevalence of 
dyslipidemias among patients undergoing 
with a higher occurrence among males (84%). 
This is close to the 73.1% reported by Burmeister 
et al. in a study carried out in patients undergoing 
haemodialysis (14). Among patients aged 50 
years and above, 94.1% practiced no physical 
activity compared to 55.6% in those 20-49 years 
old. We also noted a significant association 
between age and physical inactivity (P = 0.011). 
Our results corroborate with those of Karimi et al 
(15) who reported a correlation of advance age 
with the decrease of physical activity. Thus, 
advanced age may limit physical activity due to 
aging skeletal system resulting in functionally 
decreased muscle and bone strength, and aging of 
the articular cartilage resulting in joint pain 
during movement (16).
Tobacco Consumption
Tobacco produces acute hemodynamic 
alterations such as increased heart rate, coronary 
vascular resistance, myocardial contractility and 
myocardial oxygen demand (17). According to 
Muntner et al., tobacco consumption is 
associated with increased risk of coronary heart 
disease in patients suffering from CKD (18). 
Only 2.9% of our study participants were 
smokers, results which are close to the 5% of Hou 
et al. in a Chinese multicentric study (19), but far 
below the 11% reported by Perez-Garcia et al. in 
Spain (4). Persons at any stage of CKD require a 
good state of health and hygiene thus the low rate 
of smoking observed in our study could be 
explained by the possibility that a majority of 
these hemodialysis patients respected the 
recommended lifestyle changes.  
Hypertension
The interaction between hypertension 
and CKD is complex. On one hand hypertension 
is a potential cause of renal failure where it is 
responsible for about 30% of cases of ESRD, and 
on the other, a common consequence of chronic 
renal failure. In our study, the majority of patients 
(91.4%) were hypertensive, results which are in 
line with the findings of the CHOICE study in 
which 96% of patients with renal failure were 
hypertensive (3). Literature holds that the 
prevalence of hypertension among patients with 
end stage renal disease varies between 80% and 
90% (14, 20). We recorded mean systolic and 
diastolic BP of 148.28±14.92 mmHg and 
86.68±12.28 mmHg respectively in patients. 
These values are similar to those of the CHOICE 
(3) and the CORDIAL (14) studies, but higher 
than those reported by Hou et al (19). In 
accordance with the CORDIAL study (14), we 
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study shows that cardiovascular diseases risk 
factors frequently occur in dialysis patients with 
end stage renal disease. Among these classical 
cardiovascular disease risk factors studied, 
hypertension is the most encountered risk factor, 
followed by lipid disorders and physical 
inactivity.
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Table 1: Distribution of cardiovascular disease risk factors by gender 
 
Variables 
Men Women Total p-value 
N % N % N %  
Overall 25 100 10 100 35 100  
Physical inactivity        
 No 4 16.0 5 50.0 9 25.7 
0.053 
 Yes 21 84.0 5 50.0 26 74.3 
Alcohol consumption        
 No 17 68.0 10 100 27 77.1 
0.064 
 Yes 8 32.0 0 0 8 22.9 
Tobacco consumption        
 No 24 96.0 10 100 34 97.1 
0.714 
 Yes 1 4.0 0 0 1 2.9 
Hypertension        
 No 3 12.0 0 0 3 8.6 
0.351 
 Yes 22 88.0 10 100 32 91.4 
Diabetes        
 No 20 80.0 7 70.0 27 77.1 
0.330 
 Yes 5 20.0 3 30.0 8 22.9 
Dyslipidemia        
 No 3 12.0 2 20.0 5 14.3 
0.045 
 Yes 22 88.0 8 80.0 30 85.7 
Body Mass Index        
 Underweight 2 8.0 1 10.0 3 8.5  
 Normal body mass index  12 48.0 4 40.0 18 51.4 
0.365 
 Overweight 7 28.0 2 20.0 9 25.7 
 Obesity 2 8.0 3 30.0 5 14.8  
Mean values (Mean ± SD)     
 Systolic blood pressure (mmHg) 148.76 ± 12.51 147.1 ± 20.53 148.28 ±14.92 0.771 
 Diastolic blood pressure (mmHg) 83.96 ± 12.41 93.5 ± 9.30 86.68 ± 12.28 0.036* 
 Body mass index (kg/m²) 22.13 ± 3.74 24 ± 3.76 23.06 ± 3.75 0.069 
 Fasting Blood Glucose (g/L) 0.97 ± 0.26 1.07 ± 0.38 1.00 ± 0.29 0.368 
 Total Cholesterol (mmol/L) 3.63 ± 1.43 3.90 ± 0.83 3.71 ± 1.28 0.585 
 Triglyceride (mmol/L) 1.48 ± 0.94 1.88 ± 0.83 1.60 ± 0.93 0.258 
 HDL Cholesterol (mmol/L) 0.78 ± 0.29 1.21 ± 0.79 0.91 ± 0.51 0.024* 
 LDL Cholesterol (mmol/L) 2.30 ± 0.93 2.01 ± 0.81 2.22 ± 0.90 0.386 
 Total Cholesterol-to-HDLc ratio 5.04 ± 2.17 4.53 ± 1.50 4.89 ± 2.00 0.501 
*P<0.05. HDL: high density lipoprotein. LDL: low density lipoprotein. 
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Table 2: Distribution of cardiovascular disease risk factors by age group 
 
Variables 
20 to 49 years = 50 years p-value 
N % N %  
Overall 18 100 17 100  
Physical Inactivity      
 No 8 44.4 1 5.9 0.011* 
 Yes 10 55.6 16 94.1  
Alcohol consumption      
 No 14 77.8 13 81.2 0.571 
 Yes 4 22.2 4 18.8  
Tobacco consumption      
 No 17 94.4 17 100 0.514 
 Yes 1 5.6 0 0  
Hypertension      
 No 1 5.6 2 11.8 0.478 
 Yes 17 94.4 15 88.2  
Diabetes      
 No 15 83.3 12 70.6 0.199 
 Yes 3 16.6 5 29.4  
Dyslipidemia      
 No 2 11.1 3 1.8 
0.457 
 Yes 16 88.9 14 98.2 
Body Mass Index      
 Underweight 1 5.6 2 11.8 
0.079 
 Normal body mass index  10 55.6 8 47.1 
 Overweight 5 27.8 4 23.5 
 Obesity 2 11.1 3 1.8 
Mean Values (Mean ± SD)    
 
Systolic blood pressure 
(mmHg) 
149.72±14.18 146.76 ± 15.96 0.566 
 
Diastolic blood pressure 
(mmHg) 
86.86 ± 13.82   86.68 ± 10.83 0.943 
 Body mass index (kg/m²) 21.15 ± 3.24 23.79 ± 3.55 0.579 
 
Fasting Blood Glucose 
(g/L) 
0.89 ± 0.25 1.12 ± 0.3 0.020* 
 Total Cholesterol (mmol/L) 3.61 ± 1.07 3.81 ± 1.51 0.664 
 Triglyceride (mmol/L) 1.27 ± 0.68 1.94 ± 1.04 0.030* 
 HDL Cholesterol (mmol/L) 0.91 ± 0.46 0.91 ± 0.58 0.989 




4.48 ± 1.73 5.33 ± 2.21 0.216 
*P<0.05. HDL: high density lipoprotein. LDL: low density lipoprotein. 
>
 
Table 3: Distribution of Cardiovascular Disease Risk Factors by duration of dialysis 
 
Variables 
Less than 1 year 1 to 5 years  5 to 10 years p-value 
N % N % N %  
Overall 12 100 16 100 7 100  
Physical Inactivity        
 No 5 41.7 1 6.3 3 42.9 
0.126 
 Yes 7 58.3 15 93.8 4 57.1 
Alcohol consumption        
 No 11 91.7 14 87.5 2 28.6 
0.001* 
 Yes 1 8.3 2 12.5 5 71.4 
Tobacco consumption        
 No 12 100 15 93.8 7 100 
0.615 
 Yes 0 0 1 6.3 0 0 
Hypertension        
 No 0 0 3 18.8 0 0 
0.212 
 Yes 12 100 13 81.3 7 100 
Diabetes        
 No 9 75 13 81.2 5 71.4 
0.443 
 Yes 3 25 3 18.8 2 28.6 
Dyslipidemia        
 No 4 33.3 1 6.2 0 0 
0.512 
 Yes 8 66.7 15 93.8 7 100 
Body Mass Index        
 Underweight 0 0 2 12.5 1 14.3 
0.096 
 Normal body mass index 7 58.3 8 50.0 3 42.9 
 Overweight 4 33.3 3 18.8 2 28.6 
 Obesity 1 8.3 3 18.8 1 14.3 
Mean Values (Mean± SD)     
 Systolic blood pressure (mmHg) 157.33 ± 9.27 143.00 ± 6.65 145.6 ± 4.92 0.028* 
 Diastolic blood pressure (mmHg) 95.33 ± 7.57 81.33 ± 12.7 85.2 ± 9.09 0.005* 
 Body mass index (kg/m²) 23.52 ± 4.11  22.00 ± 3.43 22.9 ± 4.41 0.126 
 Fasting Blood Glucose (g/L) 1.06 ± 0.41 1.01 ± 0.22 0.83 ± 0.17 0.342 
 Total Cholesterol (mmol/L) 4.01 ± 1.23 3.58 ± 1.44 3.41 ± 0.8. 0.606 
 Triglyceride (mmol/L) 1.64 ± 1.08 1.63 ± 0.97 1.37 ± 0.18 0.845 
 HDL Cholesterol (mmol/L) 1.05 ± 0.62 0.84 ± 0.48 0.80 ± 0.33 0.487 
 LDL Cholesterol (mmol/L) 2.03 ± 0.70 2.39 ± 1.04 2.02 ± 0.77 0.528 
 Total Cholesterol-to-HDLc ratio 4.41 ± 2.27 5.24 ± 1.87 4.84 ± 1.92 0.554 
*P<0.05. HDL: high density lipoprotein. LDL: low density lipoprotein. 
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